Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02665286 · ClinicalTrials.gov registry record · Phase 4
Orphenadrine and Methocarbamol for LBP
A Phase 4 study, sponsored by Montefiore Medical Center.
- Completed
- Registry status
- Phase 4
- Development phase
- 240
- Enrollment target
NCT02665286 is a Phase 4 study that has completed, run by Montefiore Medical Center. The registered enrollment target is 240 participants.
The verdict
NCT02665286, a Phase 4 study, has completed, sponsored by Montefiore Medical Center.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 240 participants
- Enrollment target
Study Summary
Low back pain is a common cause of visit to emergency department. It is not clear if skeletal muscle relaxants are of benefit for patients with acute low back pain. This is a randomized study to determine if skeletal muscle relaxants, when combined with naproxen, improve outcomes more than naproxen alone
Interventions
- DRUG Placebo
- DRUG Methocarbamol
- DRUG Naproxen
- DRUG Orphenadrine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 240 participants |
| Start Date | 2016-03 |
| Est. Completion | 2017-05 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02665286
The ClinicalTrials.gov registry entry for NCT02665286 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 240 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Montefiore Medical Center, which has 345 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Placebo is the first listed.
NCT02665286 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02665286 about?
NCT02665286 is a clinical study titled "Orphenadrine and Methocarbamol for LBP". Low back pain is a common cause of visit to emergency department. It is not clear if skeletal muscle relaxants are of benefit for patients with acute low back pain. This is a randomized study to determine if skeletal muscle relaxants, when combined with naproxen, improve outcomes more than naproxen ...
What is the current status of trial NCT02665286?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 240 participants. The study started on 2016-03. Estimated completion is 2017-05.
What interventions are being tested in trial NCT02665286?
The interventions under investigation include: Placebo (DRUG), Methocarbamol (DRUG), Naproxen (DRUG), Orphenadrine (DRUG).
Who is sponsoring clinical trial NCT02665286?
This trial is sponsored by Montefiore Medical Center, which has 345 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.